Da Silva Jorge Santos, Chief Executive Officer at MoonLake Immunotherapeutics (MLTX), sold 2,250 shares at $55.27 ($124K) on 2024-02-21, disclosed to the SEC on 2024-02-23.
Scheduled sale ($124k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.27 | 1,125 | $62K | 50.0% |
| 2 | $55.27 | 1,125 | $62K | 50.0% |
| Total | $55.27 avg | 2,250 | $124K | 100% |
| Filing → |
| MLTX | SELL | 2026-04-14 | $2.8M | — | Filing → |
| MLTX | SELL | 2025-12-10 | $3.0M | — | Filing → |
| MLTX | SELL | 2024-02-29 | $7.1M | — | Filing → |